Adjunctive Homeopathic Treatment of Hospitalized COVID-19 Patients (COVIHOM): A Retrospective Case Series
Overview
Authors
Affiliations
Background: and purpose. COVID-19 is a novel viral disease causing worldwide pandemia. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to hospitalized patients with confirmed symptomatic SARS-CoV-2 infection.
Patient Presentation: Thirteen patients with COVID-19 were admitted. Mean age was 73.4 ± 15.0 (SD) years. Twelve (92.3%) were speedily discharged without relevant sequelae after 14.4 ± 8.9 days. A single patient admitted in an advanced stage of septic disease died in hospital. A time-dependent improvement of relevant clinical symptoms was observed in the 12 surviving patients. Six (46.2%) were critically ill and treated in the intensive care unit (ICU). Mean stay at the ICU of the 5 surviving patients was 18.8 ± 6.8 days. In six patients (46.2%) gastrointestinal disorders accompanied COVID-19.
Conclusion: The observations suggest that adjunctive homeopathic treatment may be helpful to treat patients with confirmed COVID-19 even in high - risk patients especially since there is no conventional treatment of COVID-19 available at present.
Integrative and complementary practices in Intensive Care Units: An integrative review.
de Melo Alves Silva L, de Farias L, de Lima V, Guerrero Soares S, Paiva F, de Assis L Heliyon. 2024; 10(22):e40333.
PMID: 39634435 PMC: 11616508. DOI: 10.1016/j.heliyon.2024.e40333.
Tournier A, Fok Y, Haselen R, To A Homeopathy. 2022; 112(1):30-39.
PMID: 36183700 PMC: 9868965. DOI: 10.1055/s-0042-1750380.
Bendezu-Quispe G, Benites-Meza J, Urrunaga-Pastor D, Herrera-Anazco P, Uyen-Cateriano A, Rodriguez-Morales A Trop Med Infect Dis. 2022; 7(6).
PMID: 35736974 PMC: 9229216. DOI: 10.3390/tropicalmed7060095.
Nayak D, Gupta J, Chaudhary A, Singh K, Deshmukh A, Das D Complement Ther Clin Pract. 2022; 48:101602.
PMID: 35569230 PMC: 9080028. DOI: 10.1016/j.ctcp.2022.101602.